Hybridoma technology requires a variety of methods not commonly available in a single laboratory. 

The typical time frame from acquisition of immunizing antigen to large-scale Mab production is in the order of 3-4 months. 

Our services are available à la carte, which allows us to take a highly customizable approach to each project. We provide collaborative and consultative services to facilitate the development of appropriate antigen purification, immunization, and hybridoma screening assays.

If requested, we can handle projects from start (purification of antigen) to finish (supply of purified antibodies or a completed immunoassay). Some investigators may prefer to perform some aspects in their own laboratory. This approach is preferable, not only does it increase our capacity, but also speeds up supply of the deliverable and helps minimize costs.

Services provided for a typical project include: